HBK Investments’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-4,900,000
| Closed | -$257M | – | 839 |
|
|
2020
Q3 | $257M | Buy |
+4,900,000
| New | +$203M | 1.92% | 14 |
|
|
2019
Q1 | – | Sell |
-109,987
| Closed | -$1.21M | – | 1471 |
|
|
2018
Q4 | $1.21M | Buy |
109,987
+85,687
| +353% | +$1.19M | 0.01% | 626 |
|
|
2018
Q3 | $639K | Buy |
24,300
+5,600
| +30% | +$151K | 0.01% | 859 |
|
|
2018
Q2 | $382K | Buy |
+18,700
| New | +$401K | ﹤0.01% | 860 |
|
|
2017
Q3 | – | Sell |
-18,600
| Closed | -$314K | – | 1175 |
|
|
2017
Q2 | $314K | Sell |
18,600
-143,200
| -89% | -$2.18M | ﹤0.01% | 806 |
|
|
2017
Q1 | $2.16M | Buy |
+161,800
| New | +$2.53M | 0.02% | 312 |
|
|
2016
Q2 | – | Sell |
-83,749
| Closed | -$774K | – | 1139 |
|
|
2016
Q1 | $774K | Sell |
83,749
-85,151
| -50% | -$916K | 0.01% | 648 |
|
|
2015
Q4 | $2.51M | Buy |
168,900
+76,707
| +83% | +$1.28M | 0.02% | 362 |
|
|
2015
Q3 | $1.51M | Buy |
92,193
+46,298
| +101% | +$948K | 0.02% | 482 |
|
|
2015
Q2 | $1.05M | Buy |
+45,895
| New | +$914K | 0.01% | 552 |
|
|
2014
Q2 | – | Sell |
-98,000
| Closed | -$1.14M | – | 1086 |
|
|
2014
Q1 | $1.14M | Buy |
98,000
+81,100
| +480% | +$1.37M | 0.02% | 448 |
|
|
2013
Q4 | $299K | Sell |
16,900
-14,300
| -46% | -$240K | 0.01% | 771 |
|
|
2013
Q3 | $449K | Buy |
+31,200
| New | +$478K | 0.01% | 655 |
|
HBK Investments's MNTA Position: Q4 2020 in Review
HBK Investments sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 4,900,000 shares — an estimated $257M sold.
HBK Investments first reported a position in MNTA in Q3 2013 and held it in 13 quarters. The position peaked at $257M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- HBK Investments reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- HBK Investments sold 4,900,000 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $257M.
- HBK Investments first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2013 and held it in 13 quarters.
- HBK Investments's Momenta Pharmaceuticals, Inc. position peaked at $257M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on HBK Investments's 13F filing for Q4 2020, filed 16 Feb 2021.